CLINICAL_TRIALS
withdrawal
· 2015-08-25
Clinical Trial Update: Clofarabine for Langerhans in Pedi [Phase 2]
Summary
A Phase 2 trial of Clofarabine for pediatric Langerhans cell histiocytosis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Langerhans Cell Histiocytosis | Phase 2 | Status: WITHDRAWN